These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8918432)

  • 1. Detection of oncogene mutation from neoplastic colonic cells exfoliated in feces.
    Ratto C; Flamini G; Sofo L; Nucera P; Ippoliti M; Curigliano G; Ferretti G; Sgambato A; Merico M; Doglietto GB; Cittadini A; Crucitti F
    Dis Colon Rectum; 1996 Nov; 39(11):1238-44. PubMed ID: 8918432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. K-ras and p53 mutations in DNA extracted from colonic epithelial cells exfoliated in faeces of patients with colorectal cancer.
    Notarnicola M; Cavallini A; Cardone R; Pezzolla F; Demma I; Di Leo A
    Dig Liver Dis; 2000 Mar; 32(2):131-6. PubMed ID: 10975788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive detection through REMS-PCR technique of K-ras mutations in stool DNA of patients with colorectal cancer.
    Mixich F; Ioana M; Voinea F; Săftoiu A; Ciurea T
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):5-10. PubMed ID: 17410282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR.
    Nollau P; Moser C; Weinland G; Wagener C
    Int J Cancer; 1996 May; 66(3):332-6. PubMed ID: 8621253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple method of detecting K-ras point mutations in stool samples for colorectal cancer screening using one-step polymerase chain reaction/restriction fragment length polymorphism analysis.
    Nishikawa T; Maemura K; Hirata I; Matsuse R; Morikawa H; Toshina K; Murano M; Hashimoto K; Nakagawa Y; Saitoh O; Uchida K; Katsu K
    Clin Chim Acta; 2002 Apr; 318(1-2):107-12. PubMed ID: 11880119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ras oncogene activation in benign and malignant colorectal tumours.
    Spandidos DA; Glarakis IS; Kotsinas A; Ergazaki M; Kiaris H
    Tumori; 1995; 81(3 Suppl):7-11. PubMed ID: 7571058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved detection of K-ras codon 12 mutations in fecal exfoliated cells.
    Puig P; Urgell E; Capellá G; Villanueva A; Grau M; Sancho FJ; Pujol J; Lluís F; González-Sastre F; Mora J
    Lab Invest; 1999 May; 79(5):617-8. PubMed ID: 10334573
    [No Abstract]   [Full Text] [Related]  

  • 8. Detecting colorectal cancer in stool with the use of multiple genetic targets.
    Dong SM; Traverso G; Johnson C; Geng L; Favis R; Boynton K; Hibi K; Goodman SN; D'Allessio M; Paty P; Hamilton SR; Sidransky D; Barany F; Levin B; Shuber A; Kinzler KW; Vogelstein B; Jen J
    J Natl Cancer Inst; 2001 Jun; 93(11):858-65. PubMed ID: 11390535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients.
    Zhu D; Keohavong P; Finkelstein SD; Swalsky P; Bakker A; Weissfeld J; Srivastava S; Whiteside TL
    Cancer Res; 1997 Jun; 57(12):2485-92. PubMed ID: 9192830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ["Field cancerization"--an additional phenomenon in development of colon tumors? K-ras codon 12 mutations in normal colonic mucosa of patients with colorectal neoplasms].
    Aivado M; Gynes M; Gorelov V; Schmidt WU; Röher HD; Goretzki PE
    Chirurg; 2000 Oct; 71(10):1230-4; discussion 1234-5. PubMed ID: 11077584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent detection of K-ras mutation in stool samples of colorectal carcinoma patients after improved DNA extraction: comparison with tissue samples.
    Ito Y; Kobayashi S; Taniguchi T; Kainuma O; Hara T; Ochiai T
    Int J Oncol; 2002 Jun; 20(6):1263-8. PubMed ID: 12012008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of K-ras point mutations in the stool of patients with colorectal tumors].
    Kohata Y
    Nihon Shokakibyo Gakkai Zasshi; 1996 Jun; 93(6):391-7. PubMed ID: 8752756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The balanced induction of K-ras codon 12 and 13 mutations in mucosa differs from their ratio in neoplastic tissues.
    Kraus MC; Seelig MH; Linnemann U; Berger MR
    Int J Oncol; 2006 Oct; 29(4):957-64. PubMed ID: 16964391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K-ras mutations in sera of patients with colorectal neoplasias and long-standing inflammatory bowel disease.
    Borchers R; Heinzlmann M; Zahn R; Witter K; Martin K; Loeschke K; Folwaczny C
    Scand J Gastroenterol; 2002 Jun; 37(6):715-8. PubMed ID: 12126252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of K-ras codon 12 mutations in human feces and ages of patients with colorectal cancer (CRC).
    Chien CC; Chen SH; Liu CC; Lee CL; Yang RN; Yang SH; Huang CJ
    Transl Res; 2007 Feb; 149(2):96-102. PubMed ID: 17240321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stool.
    Villa E; Dugani A; Rebecchi AM; Vignoli A; Grottola A; Buttafoco P; Losi L; Perini M; Trande P; Merighi A; Lerose R; Manenti F
    Gastroenterology; 1996 May; 110(5):1346-53. PubMed ID: 8613038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between overexpression of ras p21 oncoprotein and K-ras codon 12 and 13 mutations in Turkish colorectal cancer patients.
    Akkiprik M; Celikel CA; Düşünceli F; Sönmez O; Güllüoğlu BM; Sav A; Ozer A
    Turk J Gastroenterol; 2008 Mar; 19(1):22-7. PubMed ID: 18386236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sampling method as a key factor in identifying K-ras oncogene mutations in preneoplastic colorectal lesions.
    Ronai Z; Minamoto T; Butler R; Tobi M; Luo FQ; Zang E; Esumi H; Sugimura T
    Cancer Detect Prev; 1995; 19(6):512-7. PubMed ID: 8925520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordance between K-ras mutations in bone marrow micrometastases and the primary tumor in colorectal cancer.
    Tórtola S; Steinert R; Hantschick M; Peinado MA; Gastinger I; Stosiek P; Lippert H; Schlegel W; Reymond MA
    J Clin Oncol; 2001 Jun; 19(11):2837-43. PubMed ID: 11387355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal multiple molecular tests to detect colorectal cancer in stool.
    Calistri D; Rengucci C; Bocchini R; Saragoni L; Zoli W; Amadori D
    Clin Gastroenterol Hepatol; 2003 Sep; 1(5):377-83. PubMed ID: 15017656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.